Menu

How Red Blood Cells Get Their Dimples

Myosin proteins tug on the cell membrane, giving an erythrocyte its distinct shape.

Sep 1, 2018
Ashley Yeager
IN A PINCH: In healthy red blood cells (RBCs), myosin fibers (blue) contract, pulling on actin (pink) and spectrin proteins (purple) connected to the cell membrane and helping to give the cells their distinct, indented shape (top). When the myosin fiber is experimentally manipulated so that it slackens or detaches from the cell-membrane proteins, red blood cells instead take on an oval shape (bottom). See full infographic: WEB | PDF
© kimberly battista

EDITOR’S CHOICE IN CELL & MOLECULAR BIOLOGY

The paper

A.S. Smith et al., “Myosin IIA interacts with the spectrin-actin membrane skeleton to control red blood cell membrane curvature and deformability,” PNAS, 115:E4377–85, 2018.

Healthy red blood cells are puffy with a dimpled middle. “It’s just a really cool shape,” says Velia Fowler, a cell biologist at The Scripps Research Institute in San Diego. For decades, researchers have been wondering what gives red blood cells their characteristic curves, and now Fowler and her colleagues have the answer: myosin proteins tug on the red blood cell’s cytoskeletal membrane, creating a divot at the center.

Back in the 1980s, when Fowler started working with red blood cells, it wasn’t clear whether they even contained myosin. She suspected they might, because the protein appeared to play a role in giving other cells their shapes. After painstaking experiments, Fowler finally showed that red blood cells do carry the protein, but exactly how it influenced erythrocytes’ shape remained a mystery. “We didn’t have the tools to do those experiments then,” she says. The myosin filaments in red blood cells are tiny, only around 200 to 450 nanometers long, making them extremely challenging to image. And the first inhibitor of myosin IIA—the specific protein found in red blood cells—wasn’t developed until the early 2000s, so scientists couldn’t see what happened when the protein wasn’t functioning in the cells.

In the new study, the team attached an immunofluorescent tag to myosin and a phalloidin tag to actin in human red blood cells and observed the cells with both superresolution and total internal reflection fluorescence microscopy. Filaments of myosin attach to filaments of actin and the scaffolding protein spectrin that lie just beneath and parallel to the cell membrane, the team found. When myosin and actin interact and myosin contracts, the cell membrane stiffens, giving the cell a dimple at its center. Inhibiting the motor activity of the protein causes the myosin filaments to expand so they no longer tug on spectrin and actin. That leads to less tension in the membrane and, ultimately, the disappearance of the dimple.

By expanding and contracting, the myosin filaments likely make it possible for red blood cells to shape-shift as they tumble in the bloodstream’s shear flow and squeeze through microvessels such as capillaries, then pop back into their dimpled form, Fowler says.

This discovery could also give clues to how myosin works in other types of cells, Vann Bennett, a biochemist at Duke University who was not involved in the new study, tells The Scientist. “Red blood cells are a true experiment of nature,” he says. “They’ve gotten rid of the cell nucleus, mitochondria, and all cytoskeletal proteins.” These simplified cells “have been a powerhouse for generating concepts about how [plasma] membranes are organized in other cell types,” Bennett explains. Understanding the importance of myosin’s contraction in shaping red blood cells, he says, may help in teasing out its functions in other cell types.

Another recent study supports myosin’s widespread importance in maintaining cell structure: the research showed the protein is critical for axons to grow and shape themselves, suggesting it could be involved in brain plasticity (Neuron, 97:P555–70.E6, 2018).

March 2019

Going Under

Dissecting the effects of anesthetics

Marketplace

Sponsored Product Updates

The Complex Biology of Macrophages: Origins, Functions, and Activation States
The Complex Biology of Macrophages: Origins, Functions, and Activation States
Download this poster from R&D Systems for a detailed overview of macrophage markers, functions, development, specialization, and activation!
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
A Guide to Measuring Drug-Target Residence Times with Biochemical Assays
Download this guide from BellBrook Labs to learn about how to use Transcreener® biochemical assays to measure drug-target residence times, complete with examples and case studies!
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
Beckman Coulter Life Sciences To Launch New Product Via Live Stream Event
After visiting labs around the world to identify ways to advance its industry-leading cell counting technology, Beckman Coulter Life Sciences will host a live streaming event on March 26 at 10 a.m. EDT / 7 a.m. PDT to announce its latest product innovation.  
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics to Present First Data and Unveil Details for its alphalex™-PARP Inhibitor Lead Candidate CBX-11 at AACR Annual Meeting 2019
Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today announced that Vishwas Paralkar, PhD, Chief Scientific Officer of Cybrexa, will present the first set of preclinical data supporting its alphalex™-PARP inhibitor lead candidate, CBX-11, at the American Association for Cancer Research (AACR) Annual Meeting 2019, being held March 29 – April 3 in Atlanta, Georgia. At the meeting, the Company will unveil the FDA-approved poly ADP-ribose polymerase (PARP) inhibitor conjugated in CBX-11.